SE511648C2 - Streptokockpreparat för behandling av öroninflammation - Google Patents

Streptokockpreparat för behandling av öroninflammation

Info

Publication number
SE511648C2
SE511648C2 SE9801337A SE9801337A SE511648C2 SE 511648 C2 SE511648 C2 SE 511648C2 SE 9801337 A SE9801337 A SE 9801337A SE 9801337 A SE9801337 A SE 9801337A SE 511648 C2 SE511648 C2 SE 511648C2
Authority
SE
Sweden
Prior art keywords
streptococcus
ncimb
otitis
pharmaceutical preparation
strains
Prior art date
Application number
SE9801337A
Other languages
English (en)
Swedish (sv)
Other versions
SE9801337L (sv
SE9801337D0 (sv
Inventor
Haakansson Eva Grahn
Kristian Roos
Stig Holm
Original Assignee
Bacterum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bacterum Ab filed Critical Bacterum Ab
Priority to SE9801337A priority Critical patent/SE511648C2/sv
Publication of SE9801337D0 publication Critical patent/SE9801337D0/xx
Priority to IL13895899A priority patent/IL138958A0/xx
Priority to CA002325805A priority patent/CA2325805A1/en
Priority to IDW20002358A priority patent/ID26655A/id
Priority to PCT/SE1999/000608 priority patent/WO1999053932A1/en
Priority to EP99925517A priority patent/EP1071437A1/en
Priority to PL99343547A priority patent/PL343547A1/xx
Priority to JP2000544336A priority patent/JP2002512196A/ja
Priority to AU41777/99A priority patent/AU4177799A/en
Publication of SE9801337L publication Critical patent/SE9801337L/xx
Publication of SE511648C2 publication Critical patent/SE511648C2/sv
Priority to NO20005141A priority patent/NO20005141L/no
Priority to IS5661A priority patent/IS5661A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9801337A 1998-04-17 1998-04-17 Streptokockpreparat för behandling av öroninflammation SE511648C2 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9801337A SE511648C2 (sv) 1998-04-17 1998-04-17 Streptokockpreparat för behandling av öroninflammation
AU41777/99A AU4177799A (en) 1998-04-17 1999-04-16 Streptococcus preparation
PCT/SE1999/000608 WO1999053932A1 (en) 1998-04-17 1999-04-16 Streptococcus preparation
CA002325805A CA2325805A1 (en) 1998-04-17 1999-04-16 Streptococcus preparation
IDW20002358A ID26655A (id) 1998-04-17 1999-04-16 Pembuatan streptokokus
IL13895899A IL138958A0 (en) 1998-04-17 1999-04-16 Streptococcus preparation
EP99925517A EP1071437A1 (en) 1998-04-17 1999-04-16 Streptococcus preparation
PL99343547A PL343547A1 (en) 1998-04-17 1999-04-16 Streptococcus preparation
JP2000544336A JP2002512196A (ja) 1998-04-17 1999-04-16 連鎖球菌製剤
NO20005141A NO20005141L (no) 1998-04-17 2000-10-13 Streptokokkpreparat
IS5661A IS5661A (is) 1998-04-17 2000-10-13 Blanda sem inniheldur streptokokka

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801337A SE511648C2 (sv) 1998-04-17 1998-04-17 Streptokockpreparat för behandling av öroninflammation

Publications (3)

Publication Number Publication Date
SE9801337D0 SE9801337D0 (sv) 1998-04-17
SE9801337L SE9801337L (sv) 1999-10-18
SE511648C2 true SE511648C2 (sv) 1999-11-01

Family

ID=20410988

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801337A SE511648C2 (sv) 1998-04-17 1998-04-17 Streptokockpreparat för behandling av öroninflammation

Country Status (11)

Country Link
EP (1) EP1071437A1 (is)
JP (1) JP2002512196A (is)
AU (1) AU4177799A (is)
CA (1) CA2325805A1 (is)
ID (1) ID26655A (is)
IL (1) IL138958A0 (is)
IS (1) IS5661A (is)
NO (1) NO20005141L (is)
PL (1) PL343547A1 (is)
SE (1) SE511648C2 (is)
WO (1) WO1999053932A1 (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060258596A1 (en) * 2003-02-14 2006-11-16 Walsh Timothy R Antimicrobial agents
PL2349295T3 (pl) 2008-11-17 2017-06-30 Winclove Holding B.V. Preparat farmaceutyczny zawierający kombinację szczepów paciorkowców i szczepów lactobacillus
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
PL3015109T3 (pl) * 2014-10-28 2020-04-30 D.M.G. Italia Srl Bariera biologiczna z simetikonem do zastosowania w leczeniu zakażeń nosowo-gardłowo-przewodowych
CN119464165B (zh) * 2025-01-16 2026-02-24 中日友好医院(中日友好临床医学研究所) 口腔链球菌zrsor-5及其相关产品、方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
SE463349B (sv) * 1989-02-15 1990-11-12 Grahn Eva E Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit

Also Published As

Publication number Publication date
SE9801337L (sv) 1999-10-18
CA2325805A1 (en) 1999-10-28
AU4177799A (en) 1999-11-08
JP2002512196A (ja) 2002-04-23
ID26655A (id) 2001-01-25
EP1071437A1 (en) 2001-01-31
IL138958A0 (en) 2001-11-25
NO20005141D0 (no) 2000-10-13
PL343547A1 (en) 2001-08-27
NO20005141L (no) 2000-12-14
WO1999053932A1 (en) 1999-10-28
IS5661A (is) 2000-10-13
SE9801337D0 (sv) 1998-04-17

Similar Documents

Publication Publication Date Title
CN1639318B (zh) 抗微生物组合物
Edelstein et al. Susceptibility of Legionella pneumophila to twenty antimicrobial agents
Alcaide et al. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood
Speller et al. Epidemic infection by a gentamicin-resistant Staphylococcus aureus in three hospitals
Archer et al. Antibiotic-resistant Staphylococcus epidermidis in patients undergoing cardiac surgery
Ramírez-Ronda et al. Increased pharyngeal bacterial colonization during viral illness
Baddour et al. Phenotypic variation of Staphylococcus epidermidis in infection of transvenous endocardial pacemaker electrodes
Rice et al. Vancomycin resistance in the enterococcus: relevance in pediatrics
Loganathan et al. Comparative study of bacteriology in recurrent tonsillitis among children and adults
Baltch et al. Bacteremia in patients undergoing oral procedures: study following parenteral antimicrobial prophylaxis as recommended by the American Heart Association, 1977
Seifert et al. Micrococcus luteus endocarditis: case report and review of the literature
Scheifele et al. Frequency of ampicillin-resistant Haemophilus parainfluenzae in children
Archer et al. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis
SE511648C2 (sv) Streptokockpreparat för behandling av öroninflammation
Bongaerts et al. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections
Christensen et al. Bacteremia caused by a beta‐lactamase producing strain of Branhamella catarrhalis: A case report
Morris et al. Relapsing peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis due to Corynebacterium aquaticum
Tano et al. Bacterial interference between pathogens in otitis media and alpha-haemolytic Streptococci analysed in an in vitro model
De Champs et al. Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit
Zackrisson et al. In-vitro sensitivity of Bordetella pertussis
Otajevwo et al. A study on resistance loss of multidrug resistant (MDR) Pseudomonas aeruginosa strains after treatment with dilutions of acridine orange
Leuenberger et al. Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: a comparative double-blind study
Senneville et al. Failure of intravenous antibiotic therapy of multiple temporal brain abscesses due to Propionibacterium acnes requiring temporal lobectomy
Drago et al. Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone
US20240325466A1 (en) Microbiome-based composition for preventing and treating multidrug-resistant bacterial infections

Legal Events

Date Code Title Description
NUG Patent has lapsed